MDR is frequently observed in patients with leukemia and breast cancer treated with different drug regimens currently applied in the clinical practice, and one of the causes has been associated with the acquisition of high P-gp expression [1,2,3,4,5,6,7]. Here, PGP is linked to breast carcinoma.